New Jersey A4852 allows telemedicine and telehealth for prescribing Schedule II controlled substances without in-person examination or review.

New Jersey A4852 revises the requirements for prescribing Schedule II controlled dangerous substances via telemedicine and telehealth. The bill eliminates the need for an in-person examination or review when a health care provider uses interactive, real-time, two-way audio and video technologies. It also ensures that telemedicine and telehealth services meet the same standard of care as in-person settings.

New Jersey A4852 allows telemedicine and telehealth for prescribing Schedule II controlled substances without in-person examination or review.

New Jersey A4852 revises the requirements for prescribing Schedule II controlled dangerous substances via telemedicine and telehealth. The bill eliminates the need for an in-person examination or review when a health care provider uses interactive, real-time, two-way audio and video technologies. It also ensures that telemedicine and telehealth services meet the same standard of care as in-person settings.